L L Leung

1.3k total citations
11 papers, 1.1k citations indexed

About

L L Leung is a scholar working on Hematology, Cancer Research and Molecular Biology. According to data from OpenAlex, L L Leung has authored 11 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 6 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in L L Leung's work include Protease and Inhibitor Mechanisms (6 papers), Platelet Disorders and Treatments (4 papers) and Blood properties and coagulation (3 papers). L L Leung is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Platelet Disorders and Treatments (4 papers) and Blood properties and coagulation (3 papers). L L Leung collaborates with scholars based in United States. L L Leung's co-authors include Ralph L. Nachman, Roy L. Silverstein, Enrique Rabellino, R L Nachman, P C Harpel, Beatrice S. Knudsen, Adam S. Asch, Joan Rankin Shapiro, David Grant and Katsuyasu Saigo and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

L L Leung

11 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L L Leung United States 9 686 335 304 214 208 11 1.1k
M De Mol Belgium 11 747 1.1× 435 1.3× 915 3.0× 299 1.4× 257 1.2× 14 1.5k
John Lawler United States 11 364 0.5× 403 1.2× 327 1.1× 118 0.6× 91 0.4× 16 860
June D. Wencel-Drake United States 12 547 0.8× 174 0.5× 78 0.3× 203 0.9× 407 2.0× 13 904
Michael Cunningham United States 9 962 1.4× 386 1.2× 111 0.4× 295 1.4× 719 3.5× 14 1.6k
T K Vu United States 10 1.1k 1.7× 388 1.2× 304 1.0× 68 0.3× 100 0.5× 10 1.5k
Grainne A. McMahon United States 12 234 0.3× 578 1.7× 439 1.4× 92 0.4× 214 1.0× 13 1.0k
Jocelyn M. Auger United Kingdom 20 1.2k 1.8× 310 0.9× 74 0.2× 337 1.6× 343 1.6× 26 1.7k
Quteba Ebrahem United States 18 244 0.4× 808 2.4× 408 1.3× 107 0.5× 78 0.4× 31 1.5k
Sebastian Dütting Germany 12 360 0.5× 256 0.8× 74 0.2× 120 0.6× 89 0.4× 18 846
Cecilia A. Fernández United States 15 140 0.2× 864 2.6× 554 1.8× 156 0.7× 177 0.9× 21 1.6k

Countries citing papers authored by L L Leung

Since Specialization
Citations

This map shows the geographic impact of L L Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L L Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L L Leung more than expected).

Fields of papers citing papers by L L Leung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L L Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L L Leung. The network helps show where L L Leung may publish in the future.

Co-authorship network of co-authors of L L Leung

This figure shows the co-authorship network connecting the top 25 collaborators of L L Leung. A scholar is included among the top collaborators of L L Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L L Leung. L L Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Nasser, Mohammed, Anandaroop Mukhopadhyay, Kyeongah Kang, et al.. (2024). Abstract 1351: Preclinical characterization of BMS-986288, a novel non-fucosylated (NF) anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) Probody® therapeutic. Cancer Research. 84(6_Supplement). 1351–1351. 2 indexed citations
2.
Gibbs, Craig S., Steven Coutré, Manuel Tsiang, et al.. (1995). Conversion of thrombin into an anticoagulant by protein engineering. Nature. 378(6555). 413–416. 108 indexed citations
3.
Leung, L L, Katsuyasu Saigo, & David Grant. (1989). Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein. Blood. 73(1). 177–184. 44 indexed citations
4.
Leung, L L, Katsuyasu Saigo, & David Grant. (1989). Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes. Effects of histidine-rich glycoprotein. Blood. 73(1). 177–184. 7 indexed citations
5.
Knudsen, Beatrice S., Roy L. Silverstein, L L Leung, P C Harpel, & Ralph L. Nachman. (1986). Binding of plasminogen to extracellular matrix.. Journal of Biological Chemistry. 261(23). 10765–10771. 160 indexed citations
6.
Silverstein, Roy L., L L Leung, & Ralph L. Nachman. (1986). Thrombospondin: a versatile multifunctional glycoprotein.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 6(3). 245–253. 63 indexed citations
7.
Asch, Adam S., L L Leung, Joan Rankin Shapiro, & Ralph L. Nachman. (1986). Human brain glial cells synthesize thrombospondin.. Proceedings of the National Academy of Sciences. 83(9). 2904–2908. 102 indexed citations
8.
Leung, L L. (1984). Role of thrombospondin in platelet aggregation.. Journal of Clinical Investigation. 74(5). 1764–1772. 208 indexed citations
9.
Leung, L L, et al.. (1982). alpha-Actinin and membrane glycoprotein IIIa are different proteins in human blood platelets.. Proceedings of the National Academy of Sciences. 79(2). 432–435. 9 indexed citations
10.
Nachman, Ralph L. & L L Leung. (1982). Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.. Journal of Clinical Investigation. 69(2). 263–269. 270 indexed citations
11.
Rabellino, Enrique, et al.. (1981). Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes.. The Journal of Experimental Medicine. 154(1). 88–100. 152 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026